Salawu Fatai, Olokoba Abdulfatai
Department of Medicine, Federal Medical Centre, Yola, Nigeria ;
Department of General Internal Medicine, University of Ilorin Teaching Hospital, Ilorin. Nigeria.
Oman Med J. 2015 Jan;30(1):3-10. doi: 10.5001/omj.2015.02.
This article looks at the issues of excessive daytime sleepiness and unintended sleep episodes in patients with Parkinson's disease (PD) and explores the reasons why patients might suffer from these symptoms, and what steps could be taken to manage them. During the last decade, understanding of sleep/wake regulation has increased. Several brainstem nuclei and their communication pathways in the ascending arousing system through the hypothalamus and thalamus to the cortex play key roles in sleep disorders. Insomnia is the most common sleep disorder in PD patients, and excessive daytime sleepiness is also common. Excessive daytime sleepiness affects up to 50% of PD patients and a growing body of research has established this sleep disturbance as a marker of preclinical and premotor PD. It is a frequent and highly persistent feature in PD, with multifactorial underlying pathophysiology. Both age and disease-related disturbances of sleep-wake regulation contribute to hypersomnia in PD. Treatment with dopamine agonists also contribute to excessive daytime sleepiness. Effective management of sleep disturbances and excessive daytime sleepiness can greatly improve the quality of life for patients with PD.
本文探讨帕金森病(PD)患者白天过度嗜睡和意外睡眠发作的问题,探究患者出现这些症状的原因,以及可采取哪些措施来应对。在过去十年中,人们对睡眠/觉醒调节的认识有所增加。几个脑干核团及其在通过下丘脑和丘脑至皮质的上行唤醒系统中的通信通路在睡眠障碍中起关键作用。失眠是PD患者中最常见的睡眠障碍,白天过度嗜睡也很常见。高达50%的PD患者受到白天过度嗜睡的影响,越来越多的研究已将这种睡眠障碍确立为临床前和运动前PD的一个标志。它是PD中一种常见且高度持久的特征,其潜在病理生理学具有多因素性。年龄和与疾病相关的睡眠-觉醒调节紊乱均导致PD患者出现嗜睡。使用多巴胺激动剂进行治疗也会导致白天过度嗜睡。有效管理睡眠障碍和白天过度嗜睡可极大地改善PD患者的生活质量。